OBJECTIVE: Fetal dysregulation of T helper cell pathways may predispose to allergy, as high cord blood T helper 2/T helper 1 ratios have been shown to precede development of allergic diseases. We aimed to determine whether prenatal eicosapentaenoic acid and docosahexaenoic acid supplementation reduces T helper 2 to T helper 1-associated chemokine ratios. We also explored the effect of mode of delivery on T helper 2/T helper 1 ratios. STUDY DESIGN: We conducted a secondary analysis of a randomized placebo controlled trial initially performed to assess the effects of docosahexaenoic acid or eicosapentaenoic acid supplementation on pregnancy-related depressive symptoms among 126 participants. Cord plasma specimens from 98 newborns were assayed for chemokines associated with T helper 2 (thymus and activation-regulated chemokine [CCL17], macrophage-derived chemokine [CCL22], eotaxin [CCL 11]) and T helper 1 (interferon-inducible protein-10 [CXCL 10]) by enzyme-linked immunosorbent assay and Multiplex immunoassays. Ratios of log-transformed chemokines macrophage-derived chemokine/interferon-inducible protein-10 and thymus and activation-regulated chemokine/interferon-inducible protein-10 were compared between groups by analyses of variance. Multiple linear regression was performed to examine associations between treatments and chemokine ratios, adjusting for covariates. RESULTS: After adjusting for gestational age at delivery, birthweight, and mode of delivery, both omega-3 supplementation groups were associated with lower macrophage-derived chemokine/interferon-inducible protein-10 ratios than placebo (eicosapentaenoic acid: coefficient -1.8; 95% confidence interval [CI], -3.6 to -0.05; P = .04; docosahexaenoic acid: -2.0; 95% CI, -3.9 to -0.07; P = .04). Similar associations were found for thymus and activation-regulated chemokine/interferon-inducible protein-10 (eicosapentaenoic acid: -1.5; 95% CI, -3.0 to 0.06; P = .06; docosahexaenoic acid -2.2; 95% CI, -3.8 to -0.52; P = .01). Cesarean delivery was associated with higher macrophage-derived chemokine/interferon-inducible protein-10 (1.6; 95% CI, 0.01-3.3; P = .049) and thymus and activation-regulated chemokine/interferon-inducible protein-10 (1.5; 95% CI, 0.1-2.9; P = .042) ratios than vaginal delivery. CONCLUSION: Prenatal supplementation with eicosapentaenoic acid and docosahexaenoic acid resulted in decreased cord blood T helper 2/T helper 1 chemokine ratios. Cesarean delivery was associated with a pronounced T helper 2 deviation at birth.
RCT Entities:
OBJECTIVE:Fetal dysregulation of T helper cell pathways may predispose to allergy, as high cord blood T helper 2/T helper 1 ratios have been shown to precede development of allergic diseases. We aimed to determine whether prenatal eicosapentaenoic acid and docosahexaenoic acid supplementation reduces T helper 2 to T helper 1-associated chemokine ratios. We also explored the effect of mode of delivery on T helper 2/T helper 1 ratios. STUDY DESIGN: We conducted a secondary analysis of a randomized placebo controlled trial initially performed to assess the effects of docosahexaenoic acid or eicosapentaenoic acid supplementation on pregnancy-related depressive symptoms among 126 participants. Cord plasma specimens from 98 newborns were assayed for chemokines associated with T helper 2 (thymus and activation-regulated chemokine [CCL17], macrophage-derived chemokine [CCL22], eotaxin [CCL 11]) and T helper 1 (interferon-inducible protein-10 [CXCL 10]) by enzyme-linked immunosorbent assay and Multiplex immunoassays. Ratios of log-transformed chemokines macrophage-derived chemokine/interferon-inducible protein-10 and thymus and activation-regulated chemokine/interferon-inducible protein-10 were compared between groups by analyses of variance. Multiple linear regression was performed to examine associations between treatments and chemokine ratios, adjusting for covariates. RESULTS: After adjusting for gestational age at delivery, birthweight, and mode of delivery, both omega-3 supplementation groups were associated with lower macrophage-derived chemokine/interferon-inducible protein-10 ratios than placebo (eicosapentaenoic acid: coefficient -1.8; 95% confidence interval [CI], -3.6 to -0.05; P = .04; docosahexaenoic acid: -2.0; 95% CI, -3.9 to -0.07; P = .04). Similar associations were found for thymus and activation-regulated chemokine/interferon-inducible protein-10 (eicosapentaenoic acid: -1.5; 95% CI, -3.0 to 0.06; P = .06; docosahexaenoic acid -2.2; 95% CI, -3.8 to -0.52; P = .01). Cesarean delivery was associated with higher macrophage-derived chemokine/interferon-inducible protein-10 (1.6; 95% CI, 0.01-3.3; P = .049) and thymus and activation-regulated chemokine/interferon-inducible protein-10 (1.5; 95% CI, 0.1-2.9; P = .042) ratios than vaginal delivery. CONCLUSION: Prenatal supplementation with eicosapentaenoic acid and docosahexaenoic acid resulted in decreased cord blood T helper 2/T helper 1 chemokine ratios. Cesarean delivery was associated with a pronounced T helper 2 deviation at birth.
Authors: Mirka Lumia; Päivi Luukkainen; Heli Tapanainen; Minna Kaila; Maijaliisa Erkkola; Liisa Uusitalo; Sari Niinistö; Michael G Kenward; Jorma Ilonen; Olli Simell; Mikael Knip; Riitta Veijola; Suvi M Virtanen Journal: Pediatr Allergy Immunol Date: 2011-09-19 Impact factor: 6.377
Authors: A Heinzmann; X Q Mao; M Akaiwa; R T Kreomer; P S Gao; K Ohshima; R Umeshita; Y Abe; S Braun; T Yamashita; M H Roberts; R Sugimoto; K Arima; Y Arinobu; B Yu; S Kruse; T Enomoto; Y Dake; M Kawai; S Shimazu; S Sasaki; C N Adra; M Kitaichi; H Inoue; K Yamauchi; N Tomichi; F Kurimoto; N Hamasaki; J M Hopkin; K Izuhara; T Shirakawa; K A Deichmann Journal: Hum Mol Genet Date: 2000-03-01 Impact factor: 6.150
Authors: Eugen Mattes; Suzi McCarthy; Grace Gong; J Anke M van Eekelen; Janet Dunstan; Jonathan Foster; Susan L Prescott Journal: Brain Behav Immun Date: 2008-12-24 Impact factor: 7.217
Authors: Ngoc P Ly; Begoña Ruiz-Pérez; Andrew B Onderdonk; Arthur O Tzianabos; Augusto A Litonjua; Catherine Liang; Daniel Laskey; Mary L Delaney; Andrea M DuBois; Hara Levy; Diane R Gold; Louise M Ryan; Scott T Weiss; Juan C Celedón Journal: Clin Mol Allergy Date: 2006-09-26
Authors: Stella Aslibekyan; Howard W Wiener; Peter J Havel; Kimber L Stanhope; Diane M O'Brien; Scarlett E Hopkins; Devin M Absher; Hemant K Tiwari; Bert B Boyer Journal: J Nutr Date: 2014-01-29 Impact factor: 4.798
Authors: Rebecca E Fisher-Heffernan; Mamun M Or'Rashid; Ousama AlZahal; Margaret Quinton; Herman J Boermans; Brian W McBride; Timothy R H Regnault; Niel A Karrow Journal: BMC Vet Res Date: 2015-10-15 Impact factor: 2.741
Authors: Ellen L Mozurkewich; Deborah R Berman; Anjel Vahratian; Chelsea M Clinton; Vivian C Romero; Julie L Chilimigras; Delia Vazquez; Clifford Qualls; Zora Djuric Journal: BMC Pregnancy Childbirth Date: 2018-06-26 Impact factor: 3.007